Status:
COMPLETED
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study was to evaluate the performance of established and new risk predictors in predicting mortality in post-infarction patients suffering from diabetes mellitus
Eligibility Criteria
Inclusion
- acute myocardial infarction, presence of sinusrhythm
Exclusion
- \-
Key Trial Info
Start Date :
January 1 1995
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT00196235
Start Date
January 1 1995
Last Update
March 12 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
2
1. Medizinische Klinik, Klinikum rechts der Isar
Munich, Germany, 81675